Benzinga | Apr 28, 2021 09:31AM EDT

Morgan Stanley Maintains Overweight on Stryker, Raises Price Target to $280

Morgan Stanley maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $265 to $280.